358 related articles for article (PubMed ID: 38734839)
1. A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets.
Aziz N; Wal P; Patel A; Prajapati H
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38734839
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
[TBL] [Abstract][Full Text] [Related]
3. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
4. From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke.
Raghani N; Postwala H; Shah Y; Chorawala M; Parekh P
Probiotics Antimicrob Proteins; 2024 Jun; ():. PubMed ID: 38831225
[TBL] [Abstract][Full Text] [Related]
5. An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders.
Borrego-Ruiz A; Borrego JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110861. PubMed ID: 37690584
[TBL] [Abstract][Full Text] [Related]
6. Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions.
Suganya K; Koo BS
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066156
[TBL] [Abstract][Full Text] [Related]
7. Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade.
Sharma P; Agrawal A
Neurosurg Rev; 2022 Feb; 45(1):27-48. PubMed ID: 33904013
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics.
Thakkar A; Vora A; Kaur G; Akhtar J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2911-2923. PubMed ID: 37284896
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in alcohol use disorder: Implications for health outcomes and therapeutic strategies-a literature review.
Koutromanos I; Legaki E; Gazouli M; Vasilopoulos E; Kouzoupis A; Tzavellas E
World J Methodol; 2024 Mar; 14(1):88519. PubMed ID: 38577203
[TBL] [Abstract][Full Text] [Related]
12. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
[TBL] [Abstract][Full Text] [Related]
13. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
[TBL] [Abstract][Full Text] [Related]
15. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
Ma YY; Li X; Yu JT; Wang YJ
Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review.
Yadav H; Jaldhi ; Bhardwaj R; Anamika ; Bakshi A; Gupta S; Maurya SK
Life Sci; 2023 Oct; 330():122022. PubMed ID: 37579835
[TBL] [Abstract][Full Text] [Related]
17. Role of microbes in the pathogenesis of neuropsychiatric disorders.
Goswami A; Wendt FR; Pathak GA; Tylee DS; De Angelis F; De Lillo A; Polimanti R
Front Neuroendocrinol; 2021 Jul; 62():100917. PubMed ID: 33957173
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
19. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
20. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
